Corporate/Financial News Archives

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

STONY BROOK, N.Y. January 8, 2025 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it has rescheduled its Investor Update call to Thursday, February 13, 2025, to coincide with the release of its first quarter fiscal 2025 financial results. [...]

heather2025-01-08T16:22:58-05:00Categories: Corporate/Financial News, Investors, Press Release|

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

STONY BROOK, N.Y. – December 17, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today reported financial results for its fourth quarter and fiscal year ended September 30, 2024. An update on the buildout of the Company’s GMP manufacturing facility [...]

heather2024-12-18T14:21:59-05:00Categories: Corporate/Financial News, Press Release|

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

STONY BROOK, N.Y. – December 16, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its fourth quarter and fiscal year 2024 financial results after the market close on Tuesday, December 17, 2024. The Company will [...]

heather2024-12-16T09:42:08-05:00Categories: Corporate/Financial News, Press Release|

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

STONY BROOK, N.Y., October 15, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president and chief executive officer, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit. Maxim Group LLC is presenting the virtual summit [...]

heather2024-10-15T10:22:37-04:00Categories: Corporate/Financial News, Investors, Press Release|

APDN Announces $3.44M Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

STONY BROOK, N.Y., January 31, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that it has entered into securities purchase agreements (SPAs) with certain existing institutional investors (collectively the “Holders”) for the issuance and sale of an aggregate of 5,644,061 of its shares of common [...]

heather2024-05-13T15:09:23-04:00Categories: Corporate/Financial News, Press Release|

Job Posting: Specimen Accessioner

The Specimen Accessioner works closely with Applied DNA Clinical Labs personnel to catalog patient specimens, such as: swab, transport media, body fluids (blood, urine, etc.) or tissue samples, for review. Those samples are processed and examined by laboratory professionals, doctors, and nurses for diagnosis and treatment. Job Duties and Responsibilities Verifies all specimens that [...]

heather2022-01-05T12:42:02-05:00Categories: ACDL, Corporate/Financial News|Tags: Careers, Specimen Accessioner|

Job Posting: Diagnostic Sales Account Manager

The Diagnostic Sales Account Manager will be responsible for selling the portfolio of existing products and the launch of new products into established and developing markets. They will accomplish this by calling on Public Health Departments, State Department of Health Labs, Reference Laboratories, Hospitals, Infectious Disease Physicians, Pathologists, and all associated stakeholders. [...]

heather2022-01-05T12:44:50-05:00Categories: ACDL, Corporate/Financial News|Tags: Careers, Diagnostic Sales Account Manager|

Job Posting: Diagnostic Sales Representative

The Diagnostic Sales Account Representative will be responsible for selling the portfolio of existing products into established and developing markets. They will accomplish this by calling on Public Health Departments, State Department of Health Labs, Reference Laboratories, Hospitals, Infectious Disease Physicians, Physicians, Specialists, Pathologists, and all associated stakeholders. Essential Duties and Responsibilities: [...]

heather2022-01-05T12:45:12-05:00Categories: ACDL, Corporate/Financial News|Tags: Careers, Diagnostic Sales Representative|

APDN Schedules FY2’21 Financial Results Conference Call and Webcast for Thursday, May 13, 2021

STONY BROOK, N.Y. – May 7, 2021 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that it will report fiscal 2021 second quarter financial results after market close on Thursday, May 13, 2021. The Company’s management will [...]

heather2023-02-23T13:24:19-05:00Categories: Corporate/Financial News, Investors|Tags: Corporate/Financial News, press release|